@article{Rajashree Debbarma_Raghunath.G.V_Binu.M.B_2020, title={A CLINICAL EVALUATION OF JATIPHALA CHURNA LEPA IN VYANGA WSR TO MELASMA }, volume={8}, url={https://ijapr.in/index.php/ijapr/article/view/1691}, DOI={10.47070/ijapr.v8iSupply2.1691}, abstractNote={<p><em>Vyanga</em> is the one of the <em>Kshudra Roga,</em> characterised by <em>Niruja</em> (painless), <em>Shyava Varna Mandalas</em> (bluish black patches) occurring especially on the face. While considering the pathogenesis of <em>Vyanga</em>, involvement of <em>Pitta</em> is more and it is <em>Rakta Pradoshaja vyadhi</em>. On the basis of clinical features it is correlated with melasma, or facial melanosis, one of the hyper pigmented disorders. Melasma is a common acquired hypermelanosis that affects sun- exposed areas of skin. This study is important since melasma is a disease causing mental side effects in patients, due to darkness and opacity of the skin; therefore, the treatment of melasma in terms of its psychological complication is of particular importance. <em>Jatiphala</em> (<em>Myristica fragrans</em> Houtt.) is an important drug which has got various medicinal uses. The seed and aril of <em>Jatiphala</em> (<em>Myristica fragrans</em> Houtt.) of family myristicaceae have the utilized therapeutically as medicine as well as a spice. <em>Acharya Bhavamishra</em> have mentioned <em>Jatiphala</em> (<em>Myristica fragrans</em> Houtt.) as a single herbal remedy for its action on <em>Vyanga</em>.</p> <p><strong>Intervention and duration:</strong> 30 patients having hyperpigmentation on face with clinical manifestations, fulfilling the diagnostic criteria of <em>Vyanga</em>, the prepared <em>Lepa churna</em> was applied over the affected area, once a day for 60 days. Pre test assessment was done on 15<sup>th</sup> day, 30<sup>th</sup> and 60<sup>th</sup>day. <strong>Results:</strong> The subjective and objective parameters of the study were graded and the results of the study were analysed statistically using descriptive statistics where the study has shown statistically significant in the subjective and objective parameters. <strong>Conclusion:</strong> This clinical study of <em>Jatiphala churna lepa </em>showed the result in 50-60% of people in the group of <em>Vyanga.</em></p&gt;}, number={Supply2}, journal={International Journal of Ayurveda and Pharma Research}, author={Rajashree Debbarma and Raghunath.G.V and Binu.M.B}, year={2020}, month={Nov.}, pages={17-26} }